These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12615699)

  • 1. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice.
    Yamada T; Mori Y; Hayashi R; Takada M; Ino Y; Naishiro Y; Kondo T; Hirohashi S
    Cancer Res; 2003 Mar; 63(5):895-901. PubMed ID: 12615699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
    Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
    Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of beta-catenin/T-cell factor 4-mediated gene transactivation.
    Naishiro Y; Yamada T; Takaoka AS; Hayashi R; Hasegawa F; Imai K; Hirohashi S
    Cancer Res; 2001 Mar; 61(6):2751-8. PubMed ID: 11289158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of intestinal epithelial cells expressing stabilized beta-catenin.
    Seike M; Kondo T; Mori Y; Gemma A; Kudoh S; Sakamoto M; Yamada T; Hirohashi S
    Cancer Res; 2003 Aug; 63(15):4641-7. PubMed ID: 12907644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of intestinal polyp development in Apc(Min/+) mice through inhibition of P-glycoprotein using verapamil.
    Fujimoto K; Fujii G; Mutoh M; Yasunaga M; Tanaka H; Wada M
    Eur J Cancer Prev; 2013 Jan; 22(1):8-10. PubMed ID: 22504657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice.
    Møllersen L; Paulsen JE; Olstørn HB; Knutsen HK; Alexander J
    Carcinogenesis; 2004 Jan; 25(1):149-53. PubMed ID: 14514656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q; Ishikawa TO; Oshima M; Taketo MM
    Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways.
    Mabley JG; Pacher P; Bai P; Wallace R; Goonesekera S; Virag L; Southan GJ; Szabó C
    Mutat Res; 2004 Apr; 548(1-2):107-16. PubMed ID: 15063141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation.
    Hildesheim J; Belova GI; Tyner SD; Zhou X; Vardanian L; Fornace AJ
    Oncogene; 2004 Mar; 23(10):1829-37. PubMed ID: 14647429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
    Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
    Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Catenin-accumulated crypts in the colonic mucosa of juvenile ApcMin/+ mice.
    Hata K; Tanaka T; Kohno H; Suzuki R; Qiang SH; Yamada Y; Oyama T; Kuno T; Hirose Y; Hara A; Mori H
    Cancer Lett; 2006 Jul; 239(1):123-8. PubMed ID: 16168560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine.
    Andreu P; Colnot S; Godard C; Gad S; Chafey P; Niwa-Kawakita M; Laurent-Puig P; Kahn A; Robine S; Perret C; Romagnolo B
    Development; 2005 Mar; 132(6):1443-51. PubMed ID: 15716339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effects of Smad2 (madh2) null mutation on malignant progression of intestinal polyps in Apc(delta716) knockout mice.
    Takaku K; Wrana JL; Robertson EJ; Taketo MM
    Cancer Res; 2002 Aug; 62(16):4558-61. PubMed ID: 12183405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of beta-catenin expression in metastatic gastric cancer.
    Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P
    J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
    Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
    Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
    Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
    Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.